David M. Nanus

Oncology
515 6th St
Brooklyn, NY 11215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications

Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.

Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.

Journal: JCI insight
Published: August 06, 2026

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Journal: Science advances
Published: June 26, 2026

Transcription Factor ATF4 Deletion Reprograms Glucose Metabolism in Clear Cell Renal Cell Carcinoma.

Transcription Factor ATF4 Deletion Reprograms Glucose Metabolism in Clear Cell Renal Cell Carcinoma.

Journal: Cancers
Published: May 08, 2026

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020.

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020.

Journal: Urologic oncology
Published: April 30, 2026

Barriers to Health Care and Cancer Screening.

Barriers to Health Care and Cancer Screening.

Journal: JAMA network open
Published: April 14, 2026

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026

A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.

A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026

Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.

Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.

Journal: JAMA network open
Published: January 16, 2026

TMPO promotes cellular dissemination and metastasis in circulating tumor cells.

TMPO promotes cellular dissemination and metastasis in circulating tumor cells.

Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance.

Journal: JAMA oncology
Published: November 20, 2025

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Journal: Prostate cancer and prostatic diseases
Published: October 16, 2025
Showing 1-12 of 139

Last Updated: 09/26/2026